Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

About a third of them do not achieve adequate relief from traditional antidepressant medications and psychotherapy. The Pine ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

After six weeks, both the treatment group and the placebo group experienced an average 12.5-point reduction on the Montgomery-Åsberg Depression Rating Scale (MADRS). The drug also fell short in i ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Discover why psychiatrists are moving beyond single-treatment approaches and how combining therapies could be the key to ...

approved by the FDA for treatment-resistant depression in 2019 and for MDD patients at risk of suicide earlier this year – but is thought to lack some of the psychoactive effects of these drugs.